Related Experiment Video
Updated: Jun 14, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
Coagulation Factor Xa inhibits cancer cell migration via LIMK1-mediated cofilin inactivation
Keren Borensztajn1, Maikel P Peppelenbosch, C Arnold Spek
1Center for Experimental and Molecular Medicine, Academic Medical Center, Meibergdreef 9, NL-1105 AZ, Amsterdam, The Netherlands. K.S.Borensztajn@amc.uva.nl
Abstract:
Previously, we showed that activated coagulation factor X (FXa) inhibits migration of breast, lung and colon cancer cells. We showed that the effect of FXa on migration was protease-activated receptor (PAR)-1-dependent, but the subsequent cellular signaling routes remained elusive. In the current manuscript, we show that both the Rho/ROCK and Src/FAK/paxillin pathways are required for FXa-mediated inhibition of breast cancer cell migration. FXa induced pronounced stress fiber formation that was partially inhibited by pre-treatment with specific ROCK or Src inhibitors. Downstream of Rho/ROCK and Src/FAK/paxillin, FXa induced myosin light chain phosphorylation and LIMK1 activation resulting in cofilin inactivation. Knocking-down LIMK1 expression abolished FXa-induced inhibition of cell invasion. Our results reveal that FXa-mediated sustained cofilin inactivation leads to stabilization of actin filaments incompatible with migration. Overall we confirm that, beyond its role in blood coagulation, FXa plays a key role in cell migration and we unravel a new mechanism of PAR-1-mediated inhibition of migration via Rho and Src dependent pathways.
Insights
Activated coagulation factor X (FXa) inhibits cancer cell migration via protease-activated receptor 1 (PAR-1) signaling. This new research reveals FXa inactivates cofilin, stabilizing actin filaments and preventing cell movement.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Activated coagulation factor X (FXa) was previously shown to inhibit migration in breast, lung, and colon cancer cells.
- The mechanism by which FXa influences cell migration, particularly the downstream signaling pathways, remained largely unknown.
- FXa's role in cancer cell migration is mediated through protease-activated receptor 1 (PAR-1).
Purpose of the Study:
- To elucidate the cellular signaling pathways involved in FXa-mediated inhibition of breast cancer cell migration.
- To investigate the role of Rho/ROCK and Src/FAK/paxillin pathways in FXa's effect on cell motility.
- To identify key molecular events leading to FXa-induced suppression of cancer cell invasion.
Main Methods:
- Utilized specific inhibitors for ROCK and Src kinases to assess their role in FXa signaling.
- Investigated downstream signaling events including myosin light chain phosphorylation, LIMK1 activation, and cofilin inactivation.
- Employed gene knockdown of LIMK1 to determine its necessity for FXa-mediated inhibition of cell invasion.
- Analyzed stress fiber formation and actin filament stabilization in response to FXa treatment.
Main Results:
- Both Rho/ROCK and Src/FAK/paxillin pathways were identified as essential for FXa-induced inhibition of breast cancer cell migration.
- FXa treatment led to significant stress fiber formation, partially mitigated by ROCK or Src inhibition.
- FXa induced myosin light chain phosphorylation and LIMK1 activation, subsequently inactivating cofilin.
- Knockdown of LIMK1 expression abrogated the FXa-induced inhibition of cancer cell invasion.
- FXa promotes sustained cofilin inactivation, stabilizing actin filaments and hindering cell migration.
Conclusions:
- FXa plays a significant role in regulating cancer cell migration beyond its hemostatic function.
- A novel mechanism of PAR-1-mediated inhibition of cell migration involves FXa activating Rho and Src-dependent pathways.
- Sustained inactivation of cofilin by FXa stabilizes actin cytoskeleton, rendering it incompatible with cell migration and invasion.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Intracellular Signaling Affects Focal Adhesions
Some...
Regulation of Angiogenesis and Blood Supply
Inhibition of Cdk Activity
Inhibition of CDK Activity
Mechanism of Lamellipodia Formation

